Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)

NCT06025812 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus

Interventions

BIOLOGICAL: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
BIOLOGICAL: Recombinant novel coronavirus protein vaccine (CHO cells)

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.